D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder
NCT00257361 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2013-09-30
Summary
We propose to undertake an initial study of DCS to determine whether it has any short-term clinical benefits when added to standard ERP therapy in adults with OCD.
Conditions
- Obsessive Compulsive Disorder
Interventions
- DRUG
Sponsors & Collaborators
-
Obsessive Compulsive Foundation
collaborator OTHER -
University of Florida
lead OTHER
Principal Investigators
-
Eric Storch, Ph.D. · University of Florida
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
More Related Trials
-
A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
NCT00126282 ·Status: COMPLETED ·Phase: NA
-
D-Cycloserine as an Adjunct to Internet-CBT for OCD
NCT01649895 ·Status: COMPLETED ·Phase: PHASE4
-
Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
NCT02062658 ·Status: COMPLETED ·Phase: PHASE2
-
A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
NCT00371176 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy
NCT00182000 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Repeated Psilocybin Dosing in OCD
NCT05370911 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
NCT00539513 ·Status: TERMINATED ·Phase: PHASE2
-
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
NCT04131829 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia
NCT01928823 ·Status: COMPLETED ·Phase: PHASE2
-
Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder
NCT00057603 ·Status: COMPLETED ·Phase: NA
-
Study of Dextromethorphan in OCD and Related Disorders
NCT04899687 ·Status: RECRUITING ·Phase: PHASE2
-
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
NCT01411774 ·Status: COMPLETED ·Phase: PHASE3
-
Attaining and Maintaining Wellness in Obsessive-compulsive Disorder
NCT01686087 ·Status: COMPLETED ·Phase: NA
-
Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
NCT00045903 ·Status: COMPLETED ·Phase: NA
-
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
NCT05359562 ·Status: RECRUITING ·Phase: NA
-
Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder
NCT00299611 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Predicting Medication Response in Obsessive Compulsive Disorder
NCT01404871 ·Status: COMPLETED ·Phase: NA
-
Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
NCT00790868 ·Status: COMPLETED ·Phase: PHASE2
-
Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study
NCT06470893 ·Status: COMPLETED ·Phase: NA
-
Ondansetron Augmentation in Treatment-resistant OCD
NCT01303536 ·Status: COMPLETED ·Phase: PHASE4
-
Overlapping Neural Circuits in Pediatric OCD
NCT02421315 ·Status: COMPLETED ·Phase: NA
-
Treatment of Obsessive Compulsive Disorder in Children
NCT00074815 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
NCT01813019 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
NCT03356483 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine Infusion for Obsessive-Compulsive Disorder
NCT01349231 ·Status: COMPLETED ·Phase: PHASE2